Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study

Yu-Ri KIM; Jin-Seok KIM; Won-Seog KIM; Hyeon-Seok EOM; Deok-Hwan YANG; Sung-Hwa BAE; Hyo-Jung KIM; Jae-Hoon LEE; Suk-Joong OH; Sung-Soo YOON; Jae-Yong KWAK; Chul-Won CHOI; Min-Kyoung KIM; Sung-Young OH; Hye-Jin KANG; Seung-Hyun NAM; Hyeok SHIM; Joon-Seong PARK; Yeung-Chul MUN; Cheolwon SUH.
Cancer Research and Treatment ; : 1355-1362, 2023.
Artículo en Inglés | WPRIM | ID: wpr-999832

Documentos relacionados

  1. Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.
  2. Clinical outcomes after incomplete cycles of R-CHOP for diffuse large B-cell lymphoma: 10 years' real-world experience in a single institute.
  3. Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
  4. Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL.
  5. R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.
  6. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
  7. [Diagnosis and treatment of HIV-associated lymphoma: Update 202].
  8. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
  9. R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
  10. A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.